4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-23-002481
COO and General Counsel sold 15,000 shares at $37.39 ($560,850)
From the SEC's structured data for this filing
Trades in this filing
O'Brien Patrick · COO and General Counsel
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-05 | Sale : show line 1 in the form | −7,500 | $37.39 | $280,425 | 420,875 | D |
| 2023-01-05 | Sale : show line 2 in the form | −7,500 | $37.39 | $280,425 | 413,375 | D |
| Open-market sales · 15,000 sh · avg $37.39 · $560,850 | ||||||
Loading xslF345X03/doc4.xml…